Zidovudine

Specifications

30516-87-1CAS Number

623-849-4EC Number

1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dioneIUPAC Name

C10H13N5O4Chemical Formula

267.24 g/molMolecular Weight

zidovudine; 30516-87-1; Azidothymidine; 3'-Azido-3'-deoxythymidine; Retrovir; Thymidine, 3'-azido-3'-deoxy-; Zidovudinum; Compound S; Zidovudina; BW A509U; zidovudin; BWA509U; BW-A-509U; 3'-Deoxy-3'-azidothymidine; BW-A509U; DTXSID8020127; DRG-0004; 3'-azt; 3'-Azidothymidine; NSC 602670; 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione; 4B9XT59T7S; 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione; CHEBI:10110; BW-A 509U; NSC-602670; DTXCID60127; AZT Antiviral; TRIZIVIR COMPONENT ZIDOVUDINE; AZT, Antiviral; 1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)-5-methylpyrimidine-2,4-(1H,3H)-dione; AZT (Antiviral); Antiviral AZT; LAMIVUDINE/ZIDOVUDINE TEVA COMPONENT ZIDOVUDINE; 3'-Azido-2',3'-Dideoxythymidine; BWA-509U; 3' Azido 3' deoxythymidine; BWA 509U; 3' Azido 2',3' Dideoxythymidine; 1-((2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl)-5-methylpyrimidine-2,4-dione; 1-((2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl)-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione; RefChem:6356; J05AF01; 623-849-4; NSC602670; AZT; ZIDOVUDINE [AZT]; Trizivir; MFCD00006536; ZDV; 1-((2R,4S,5S)-4-AZIDO-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-5-METHYLPYRIMIDINE-2,4(1H,3H)-DIONE; CHEMBL129; 1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine; MLS000028548; Azidothymidine (AZT); NCGC00023945-05; Zidovudinum [Latin]; SMR000058351; Zidovudina [Spanish]; 399024-19-2; Propolis+AZT; Retrovir(TM); AZT & Li & EPO; Retrovir (TN); CCRIS 105; Cpd S; Intron A & AZT; HSDB 6515; Racemic Liposomal AZT; Liposomal AZT-SN-1; Liposomal AZT-SN-3; Zidovudine+PRO 140; PC-SOD+AZT; AZT & srCD4; AZT & rIFN.alpha.2; AZT & rsT4; rIFN-beta seron & AZT; 3'-Azido-3'-deoxythymidine (AIDS); AZT & EPO; AZT & GM-CSF; AZT & HPA; AZT & sCD4; AZT & SST; zudovidine; UNII-4B9XT59T7S; Zidovir; AZT & Li & GM-CSF; AZT+PRO 140; Met-SDF-1.beta. & AZT; AZT & Li & IL-1; AZT & Li & IL-6; AZT & IL-1; AZT & IL-2; AZT & IL-6; AZT & Interferon-.alpha.-2; Retrovir;; Zidovudine RS; AZT & Concanavalin A (ConA); Zidovudine CRS; Apovir;; AZT & Lymphoblastoid Interferon; AZT & PM-19; Met-SDF-1.beta. & Zidovudine; 4lhm; 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (AZT); 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione [AZT]; AZT & rsCD4 & rIFN.alpha.A; 3'-azido-3'-deoxythymidine, AZT; DS-4152 & AZT; 1-((2R,4R,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione; 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione; 5-methyl-1-[rac-(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione; AZT & Colony-stimulating factor 2; AZT & NP (from PHCA or HSA); Zidovudine; 1-(3-Azido-2,3-dideoxy-ss-d-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione; Zidovudine (GR 63367X); BP Zidovudine and Lamivudine Impurity Standard; 3'-Azidothymidine;; Novo-AZT;; S2579; 3''-azido-thymidine; K7 [P Ti2 W10 O40]; Zidovudine [USAN:USP:INN:BAN:JAN]; Zidovudine & IFNL1; Zidovudine & IFNL2; Zidovudine & IFNL3; Zidovudine (Retrovir); Zidovudine (Standard); COMPOUND-S; Spectrum_001348; AZT & CD4(178)-PE 40; AZT & IFN.alpha.; Zidovudine & IL-29; ZIDOVUDINE [MI]; Zidovudine & IL-28A; Zidovudine & IL-28B; AZT, ZDV; ZIDOVUDINE [INN]; ZIDOVUDINE [JAN]; AZT & Interleukin 29; Opera_ID_1602; Prestwick3_000333; Spectrum2_000927; Spectrum3_001507; Spectrum4_000332; Spectrum5_001101; 3'azido-3'deoxythymidine; ZIDOVUDINE [HSDB]; ZIDOVUDINE [IARC]; ZIDOVUDINE [USAN]; 3'-Azido-3'-deoxythymidine & Erythropoietin; 3'-Azido-3'-deoxythymidine & Sho-Saiko-To; Azidothymidine; Zidovudine; AZT & Interleukin 28A; AZT & Interleukin 28B; 3'-Azido-3'-deoxythymidine & Concanavalin A; 3'-Azido-3'-deoxythymidine & Interleukin-1; 3'-Azido-3'-deoxythymidine & Interleukin-2; 3'-Azido-3'-deoxythymidine & Interleukin-6; ZIDOVUDINE [VANDF]; Epitope ID:768746; 3'-azido3'-deoxythymidine; AZT & IFNL1; AZT & IFNL2; AZT & IFNL3; ZIDOVUDINE [MART.]; AZT & Interferon lambda-1; AZT & Interferon lambda-2; AZT & Interferon lambda-3; ZIDOVUDINE [USP-RS]; ZIDOVUDINE [WHO-DD]; ZIDOVUDINE [WHO-IP]; 3''-Deoxy-3-azidothymidine; BSPBio_000365; BSPBio_003153; KBioGR_000703; KBioSS_001828; 3'-N3-ddT (AZT); MLS001055351; MLS001076358; MLS002153202; MLS002222249; Zidovudine & Interleukin 29; DivK1c_000524; SPECTRUM1502109; ZIDOVUDINE [EMA EPAR]; 3'-deoxy-3'-azido-thymidine; SPBio_000834; Zidovudine & Interleukin 28A; Zidovudine & Interleukin 28B; 3'-Azido-3'-deoxythymidine;; AZT & IL-28A; AZT & IL-28B; BPBio1_000403; GTPL4825; orb1308679; orb3141292; Zidovudine (JP18/USP/INN); 3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon; SCHEMBL14615088; SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle); SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle); ZIDOVUDINE [EP IMPURITY]; ZIDOVUDINE [ORANGE BOOK]; AZT & IL-29; HMS501K06; KBio1_000524; KBio2_001828; KBio2_004396; KBio2_006964; KBio3_002653; racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle); ZIDOVUDINE [EP MONOGRAPH]; 3''-Azido-3''-deoxy-thymidine; NINDS_000524; Zidovudine & Interferon lambda-1; Zidovudine & Interferon lambda-2; Zidovudine & Interferon lambda-3; HMS1921J20; HMS2090G11; HMS2092D06; HMS2096C07; HMS2234K17; HMS3259H17; HMS3713C07; Pharmakon1600-01502109; ZIDOVUDINE [USP MONOGRAPH]; ZIDOVUDINUM [WHO-IP LATIN]; 3'-azido-3'-deoxythymidine (azt); COMBIVIR COMPONENT ZIDOVUDINE; MSK10681; 3''azido-2''3''-dideoxythymidine; Tox21_110062; Tox21_110894; Tox21_202203; Tox21_300578; BBL033764; BDBM50002692; CCG-39924; EBC-13244; EBC-66074; HY-17413R; NSC758185; STK801891; AKOS005622576; AKOS015842610; Tox21_110062_1; 3''-azido-2'',3''-dideoxythymidine; DB00495; NC00666; NSC-758185; IDI1_000524; NCGC00014918-01; NCGC00023945-03; NCGC00023945-04; NCGC00023945-06; NCGC00023945-07; NCGC00023945-08; NCGC00023945-09; NCGC00023945-10; NCGC00023945-12; NCGC00023945-13; NCGC00023945-24; NCGC00023945-25; NCGC00178237-01; NCGC00178237-02; NCGC00254276-01; NCGC00259752-01; AS-13019; SY065461; SBI-0051731.P002; DB-225998; NS00000600; Propolis & Thymidine, 3'-azido-3'-deoxy-; SW198799-2; EN300-52518; 3'-Azido-3'-deoxythymidine, >=98% (HPLC); C07210; D00413; D88500; 3'-Azido-3'deoxythymidine & Interferon .alpha.; 3'-Azido-3'-deoxythymidine, >=99.0% (HPLC); F358376; Q198504; SR-01000000098; SR-05000001587; SR-01000000098-3; SR-05000001587-1; BRD-K72903603-001-04-6; BRD-K72903603-001-14-5; BRD-K72903603-001-24-4; Z754931264; Zidovudine, European Pharmacopoeia (EP) Reference Standard; 3'-Azido-3'-deoxythymidine & Recombinant Interferon-.alpha.-2; Zidovudine, United States Pharmacopeia (USP) Reference Standard; 3'-Azido-3'-deoxythymidine & CD4-Pseudomonas exotoxin A hybrid; Beta interferon(rIFN-beta seron) & 3'-Azido-3'-deoxythymidine(AZT); Lecithinized superoxide dismutase & Thymidine, 3'-azido-3'-deoxy-; 3'-Azido-2',3'-dideoxythymidine & sCD4(soluble recombinant protein); Thymidine, 3'-azido-3'-deoxy- & PRO 140 (Anti-CCR5 monoclonal antibody); Zidovudine, Pharmaceutical Secondary Standard; Certified Reference Material; (AZT) 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione; (AZT)1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione; 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione; 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione(AZT); 3'-Azido-3'-deoxythymidine & Granulocyte-macrophage colony-stimulating factor; 3'-Azido-3'-deoxythymidine & Lithium & Granulocyte-macrophage colony-stimulating factor; 3'-Azido-3'deoxythymidine & Recombinant Soluble CD4 & Recombinant Interferon.alpha.A; 4-(4-Azido-5-hydroxy-tetrahydro-furan-2-yl)-5-methyl-3H-pyrazine-2,6-dione; Met-Stromal Cell-derived Factor-1.beta. (Human) & 3'-Azido-3'-deoxythymidine; 1-((2R,4S,5S)-4-(diazoamino)-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione; 1-((2R,4S,5S)-4-azido-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione; 1-((2R,4S,5S)-4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione; 1-((2R,5S)-4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione; 1-((2S,4R,5R)-4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione; 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (AzddThd, AZT); 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (N3ddThd); 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione(3''-azido-2'',3''-dideoxythymidine); 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione(azidothymidine, AZT); 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione(Zidovudine, AZT); 3-((2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl)triaz-1-en-2-ium-1-ideSynonyms